🇺🇸 FDA
Pipeline program

68Ga-FAPI-46

FAPI-MN-2020

Phase 2 small_molecule active

Quick answer

68Ga-FAPI-46 for oncological disease suspicion/ new diagnosis or with a previously treated tumour, with an inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: [18F]F-FDG PET/CT is a Phase 2 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
Istituto Gentili S.r.l.
Indication
oncological disease suspicion/ new diagnosis or with a previously treated tumour, with an inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: [18F]F-FDG PET/CT
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials